0001104659-22-027327.txt : 20220225
0001104659-22-027327.hdr.sgml : 20220225
20220225162654
ACCESSION NUMBER: 0001104659-22-027327
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211025
FILED AS OF DATE: 20220225
DATE AS OF CHANGE: 20220225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cotliar Jonathan
CENTRAL INDEX KEY: 0001886791
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39727
FILM NUMBER: 22680503
MAIL ADDRESS:
STREET 1: C/O LIFESCI ACQUISITION II CORP.
STREET 2: 250 W 55TH STREET, #3401
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Science 37 Holdings, Inc.
CENTRAL INDEX KEY: 0001819113
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 844278203
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 600 CORPORATE POINTE
STREET 2: SUITE 320
CITY: CULVER CITY
STATE: CA
ZIP: 90230
BUSINESS PHONE: (984)377-3737
MAIL ADDRESS:
STREET 1: 600 CORPORATE POINTE
STREET 2: SUITE 320
CITY: CULVER CITY
STATE: CA
ZIP: 90230
FORMER COMPANY:
FORMER CONFORMED NAME: Lifesci Acquisition II Corp.
DATE OF NAME CHANGE: 20200723
4
1
tm227777-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-10-25
0
0001819113
Science 37 Holdings, Inc.
SNCE
0001886791
Cotliar Jonathan
800 PARK OFFICES DRIVE, SUITE 3606
RESEARCH TRIANGLE PARK
NC
27709
0
1
0
0
Chief Medical Officer
Common Stock
2021-10-25
4
M
0
4538
0.85
A
539879
D
Common Stock
2021-10-25
4
M
0
5857
0.85
A
545736
D
Common Stock
2021-10-28
4
M
0
68074
0.40
A
613810
D
Common Stock
2021-12-02
4
M
0
977
0.85
A
614787
D
Common Stock
2021-12-02
4
M
0
11345
0.40
A
626132
D
Stock Option
0.85
2021-10-25
4
M
0
4538
0
D
2027-08-01
Common Stock
4538
0
D
Stock Option
0.85
2021-10-25
4
M
0
5857
0
D
2028-03-07
Common Stock
5857
4882
D
Stock Option
0.40
2021-10-28
4
M
0
68074
0
D
2029-06-18
Common Stock
68074
226920
D
Stock Option
0.85
2021-12-02
4
M
0
977
0
D
2028-03-07
Common Stock
977
3905
D
Stock Option
0.40
2021-12-02
4
M
0
11345
0
D
2029-06-18
Common Stock
11345
215575
D
Stock Option was fully vested and exercisable as of the date of the transaction.
Stock Option will vest in equal monthly installments until fully vested on March 7, 2022, subject to the executive's continued service through the vesting date.
Stock Option will vest in equal monthly installments until fully vested on June 19, 2023, subject to the executive's continued service through the applicable vesting date.
The total amount has been adjusted to add eight derivative securities that were not previously included due to a rounding error.
Stock Option will vest in equal monthly installments until fully vested on March 7, 2022, subject to the executive's continued service through the applicable vesting date.
Stock Option will vest in equal monthly installments until fully vested on June 19, 2023, subject to the executive's continued service through the applicable vesting date.
/s/ Christine Pellizzari, Attorney-in-Fact for Jonathan Cotliar
2022-02-25